Showing results (131-140 of 219) with videos related to

Sort By:
Pageof 22
The Oncologist|June 6, 2018
Comparative Molecular Analyses of Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, and Gastric AdenocarcinomaMohamed E Salem, Alberto Puccini, Joanne Xiu, et al.
Cancer Chemotherapy and Pharmacology|April 13, 2007
Phase-II study of dose attenuated schedule of irinotecan, capecitabine, and celecoxib in advanced colorectal cancerBassel F El-Rayes, Mark M Zalupski, Stephanie G Manza, et al.
Current Cancer Drug Targets|April 8, 2010
Reactivation of p53 by novel MDM2 inhibitors: implications for pancreatic cancer therapyAsfar S Azmi, Philip A Philip, A Aboukameel, et al.
Cancer|July 22, 2014
Dual blockade of epidermal growth factor receptor and insulin-like growth factor receptor-1 signaling in metastatic pancreatic cancer: phase Ib and randomized phase II trial of gemcitabine, erlotinib, and cixutumumab versus gemcitabine plus erlotinib (SWOG S0727)Philip A Philip, Bryan Goldman, Ramesh K Ramanathan, et al.
Oncotarget|November 22, 2017
Comparative molecular analyses of left-sided colon, right-sided colon, and rectal cancersMohamed E Salem, Benjamin A Weinberg, Joanne Xiu, et al.
International Journal of Molecular Sciences|October 2, 2019
Targeting Nuclear Exporter Protein XPO1/CRM1 in Gastric CancerRachel Sexton, Zaid Mahdi, Rahman Chaudhury, et al.
Scientific Reports|November 6, 2015
Targeting the Nuclear Export Protein XPO1/CRM1 Reverses Epithelial to Mesenchymal TransitionAsfar S Azmi, Irfana Muqbil, Jack Wu, et al.
Frontiers in Oncology|November 11, 2021
High-Risk Features Are Prognostic in dMMR/MSI-H Stage II Colon CancerAmr Mohamed, Renjian Jiang, Philip A Philip, et al.
Annals of Surgical Oncology|August 6, 2003
Histopathologic evidence of tumor regression in the axillary lymph nodes of patients treated with preoperative chemotherapy correlates with breast cancer outcomeLisa A Newman, Nat L Pernick, Volkan Adsay, et al.
Advances in Radiation Oncology|December 8, 2022
Targeting Cellular Metabolism With CPI-613 Sensitizes Pancreatic Cancer Cells to Radiation TherapyHusain Yar Khan, Mandana Kamgar, Amro Aboukameel, et al.
Pageof 22